ALMA HERNANDEZ MORRIS: Open Payments
NPI 1346997681 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 34 payments from 9 companies in 2025. Trend: 2023 $477 · 2024 $391 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $155 |
| Alkermes, Inc. | 4 | $101 |
| Janssen Pharmaceuticals, Inc | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $76 |
| ABBVIE INC. | 4 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
Products named: CAPLYTA, ARISTADA, Auvelity, COBENFY, VRAYLAR, INVEGA SUSTENNA, INGREZZA, FANAPT.
Industry payments across AR — which companies pay providers there.
